Podcast
Questions and Answers
What is the class for eptifibatide/integrilin?
What is the class for eptifibatide/integrilin?
Glycoprotein IIb/IIIa inhibitor, platelet aggregation inhibitor
What is the mechanism of action (MOA) for eptifibatide/integrilin?
What is the mechanism of action (MOA) for eptifibatide/integrilin?
Prevents the aggregation of platelets by binding to the glycoprotein receptor, preventing the binding of fibrinogen and von Willebrand factors
What are the indications for eptifibatide/integrilin?
What are the indications for eptifibatide/integrilin?
Unstable angina and NSTEMI being managed medically. Patients undergoing percutaneous coronary intervention.
What are the contraindications for eptifibatide/integrilin?
What are the contraindications for eptifibatide/integrilin?
Signup and view all the answers
What are the adverse reactions/side effects for eptifibatide/integrilin?
What are the adverse reactions/side effects for eptifibatide/integrilin?
Signup and view all the answers
What are the drug interactions for eptifibatide/integrilin?
What are the drug interactions for eptifibatide/integrilin?
Signup and view all the answers
How is eptifibatide/integrilin supplied?
How is eptifibatide/integrilin supplied?
Signup and view all the answers
What is the adult dosage for eptifibatide/integrilin?
What is the adult dosage for eptifibatide/integrilin?
Signup and view all the answers
What is the pediatric dosage for eptifibatide/integrilin?
What is the pediatric dosage for eptifibatide/integrilin?
Signup and view all the answers
What is the duration of action for eptifibatide/integrilin?
What is the duration of action for eptifibatide/integrilin?
Signup and view all the answers
Study Notes
Eptifibatide - Integrilin Overview
- Eptifibatide is classified as a glycoprotein IIb/IIIa inhibitor, specifically functioning as a platelet aggregation inhibitor.
Mechanism of Action (MOA)
- Works by binding to the glycoprotein receptor, inhibiting platelet aggregation by blocking the binding of fibrinogen and von Willebrand factors.
Indications
- Used in unstable angina and non-ST elevation myocardial infarction (NSTEMI) under medical management.
- Indicated for patients who are undergoing percutaneous coronary intervention (PCI).
Contraindications
- Contraindicated in individuals with a history of intracranial hemorrhage or known malignant intracranial neoplasm.
- Not suitable for patients with suspected aortic dissection, significant closed head or facial trauma in the last three months, active internal bleeding, bleeding disorders in the past 30 days, or recent surgical procedures/trauma within six weeks.
Adverse Reactions/Side Effects
- Potential side effects include cerebral hemorrhage, pulmonary hemorrhage, hypotension, gastrointestinal bleeding, internal bleeding, and anaphylactic shock.
Drug Interactions
- Eptifibatide's effects can be enhanced by thrombolytics, oral anticoagulants, aspirin, NSAIDs, dipyridamole, ticlopidine, and clopidogrel.
- It is incompatible with furosemide (Lasix) when administered in the same IV line.
Supply Information
- Eptifibatide is available in 2mg/mL vials and 0.75mg/mL bottles.
Adult Dosage
- Recommended initial dosage is a 180mcg/kg bolus over 1-2 minutes, followed by a continuous infusion of 2mcg/kg for 72-96 hours.
Pediatric Dosage
- The use of eptifibatide for pediatric patients is not recommended.
Duration of Action
- The onset of action occurs within minutes, with peak effects noted between 30 minutes to 4 hours.
- Platelet function typically recovers within 4-8 hours after discontinuation of the drug.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
Test your knowledge on eptifibatide, also known as Integrilin, through these flashcards. Learn about its classification, mechanism of action, and clinical indications. This quick review is perfect for students and healthcare professionals alike.